Piper Sandler Raises CME Price Target to $330

CME Group Inc. (CME) business photo

Key Points

  • Piper Sandler reiterated an Overweight rating on CME Group Inc. on October 22, 2026, while raising its price target to $330.00 from $295.00.
  • Piper Sandler's $330 price target implies 11.57% upside from CME Group Inc.'s ($CME) current $295.79 share price.
  • CME Group shares recently traded at $295.79, sitting about 7.6% above their 50-day moving average of $274.96.
  • The financial exchange operator carries a consensus hold rating from analysts alongside a mean price target of $292.94.

Get CME Group text alerts

We text you when insiders, Congress, analysts or big funds move on $CME.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures

On October 22, 2026, Piper Sandler reiterated its Overweight rating on CME Group Inc. (NASDAQ: CME) while boosting its price target from $295.00 to $330.00. The research note arrived alongside a flurry of updates from other Wall Street firms tracking the derivatives marketplace.

CME CME Group Inc.
$295.79 +13.42% year to date
Daily close · Oct 21, 2026

Piper Sandler's Call on CME Group Inc.

In its research note issued on October 22, 2026, Piper Sandler maintained its Overweight stance on the stock. The firm moved its target to $330.00 from its previous level of $295.00, reflecting confidence in the exchange operator's outlook.

Other Institutional Activity in CME Group Inc.

Large investment firms continue adjusting their holdings in the exchange operator. Carnegie Investment Counsel trimmed its stake by 7,393 shares, ending with 152,288 shares worth about $37.86 million. Meanwhile, Sanders Capital, LLC grew its holdings by 906,692 shares, ending with 5,067,740 shares worth about $1.55 billion.

CME Group Inc. Stock Up 0.8%

CME Group shares recently traded around $295.79 as of October 22, 2026, down about 3.6% from their event-day close of $306.73. The stock sits about 7.6% above its 50-day moving average of $274.96 and roughly 6.0% above its 200-day moving average of $278.92. The recent price leaves the shares about 10.1% below their 52-week high of $329.16 and well above their 52-week low of $218.31.

12-month forecast

$CME price target

CME Group Inc. daily closes and this analyst's $330 target. Not advice.

Recent Earnings

CME Group posted trailing twelve-month revenues of $6.76 billion alongside basic trailing earnings of $11.79 per share. The company operates with a trailing price-to-earnings ratio of 25.05 and a net profit margin of 63.4%.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 28/100

Reported Apr 22, 2026

  1. Forward outlook

    2 target cuts vs 0 raises.

  2. EPS & revenue

    EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.

  3. Profit surprise

    EBITDA missed by 6 percent. Operating income missed by 5 percent.

  4. Pre-earnings setup

    Expectations were about average.

  5. Analyst signal

    2 target cuts.

  6. Earnings quality

    Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.

Earnings Call Summary

CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.

Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Dividend

CME Group pays an annual dividend of $5.20 per share, which translates to a dividend yield of 1.76% based on recent trading levels.

Insider Buying and Selling at CME Group Inc.

Company insiders completed several transactions in recent months. Chief Executive Officer Terrence A Duffy sold 15,000 shares on September 10, 2026, for a total value of $4.12 million. Director Elizabeth A Cook sold 500 shares on September 14, 2026. Director William R Shepard made two separate share purchases during the period, buying 339 shares on June 25, 2026, and another 292 shares on September 25, 2026.

Analysts Set New Price Targets

Wall Street firms actively adjusted their views on the stock around the October 22, 2026 date. Wells Fargo maintained its Overweight rating while lifting its target to $333.00 from $315.00 on October 22, following an earlier update from the same firm on October 14. Barclays maintained an Equal-Weight rating with a target of $321.00 on October 22. JP Morgan initiated coverage with an Overweight rating and a $367.00 price target on October 22. Overall, the stock carries a consensus hold rating from 16 analyst opinions with a mean target of $292.94.

About CME Group Inc.

Headquartered in Chicago, Illinois, CME Group Inc. operates contract markets for trading futures and options products. The company provides venues for trading futures based on interest rates, foreign exchange, equity indexes, and various commodities.

Bottom Line

Piper Sandler's higher target sits above the current analyst consensus mean of $292.94, highlighting differing views across Wall Street. Investors will monitor upcoming earnings reports and further institutional filings for signs of shifting momentum.

Source: Piper Sandler's rating change on $CME (Oct 22, 2026). Written by software, not financial advice. How we make alerts

Get $CME trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions